ScanWatch is the latest in a range of hybrid smartwatches from French health and fitness company Withings. First announced at CES back in January, ScanWatch is finally going on sale after some pandemic-induced delays. It's now received the CE marking in Europe that clinically validates the detection of atrial fibrillation (Afib) and overnight breathing disturbances. FDA approval and a US launch are expected later this year.
Read More